Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03735290
Title A Study to Evaluate the Safety and Effectiveness of ILIxadencel Administered Into Tumors in Combination With Checkpoint Inhibitor (CPI) in Patients With ADvanced Cancer (ILIAD)
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Immunicum AB

gastric adenocarcinoma

lung non-small cell carcinoma

gastroesophageal junction adenocarcinoma

head and neck squamous cell carcinoma



Intuvax + Pembrolizumab

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.